How much funding has ObsEva raised?

ObsEva has raised $111.0M in total funding, most recently a Venture Round.

Where is ObsEva headquartered?

ObsEva is headquartered in Geneva, Switzerland.

What industry is ObsEva in?

ObsEva operates in Biotech, Reproductive Health.

ObsEva

Closed

Public · Geneva, Switzerland · Founded 2012 · $111.0M raised

Biotech

Reproductive Health

Headquarters: Geneva
Employees: 11–50
Founded: 2012
Business Model: B2B

Total Funding: $111.0M
Last Round: $20.0M Venture RoundSep 2020
Rounds: 3
Type: Public

About

Founded in 2012 and headquartered in Geneva, Switzerland, ObsEva SA (formerly Nasdaq: OBSV) was a biopharmaceutical company focused on developing and commercializing novel therapies for conditions in women's reproductive health and pregnancy. The company's pipeline included linzagolix (GnRH receptor antagonist for uterine fibroids and endometriosis) and ebopiprant (for preterm labor). ObsEva completed an IPO in 2018. Due to financial difficulties, the company undertook a strategic reorganization in 2023 and ultimately wound down operations and laid off all employees in February 2024.

Summary

ObsEva is a Biotech company based in Geneva, Switzerland, founded in 2012. It has raised $111.0M in total across 3 rounds, most recently a $20.0M Venture Round round in Sep 2020.